Always love seeing relatively low OS's too.
As of August 2, 2010, there were 28,831,089 shares of the registrant's Common Stock outstanding.
As of August 2, 2010, there were 28,831,089 shares of the registrant's Common Stock outstanding.
Recent SWTX News
- SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology • GlobeNewswire Inc. • 10/21/2025 06:00:13 AM
- European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors • GlobeNewswire Inc. • 08/18/2025 01:10:52 PM
- European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN • GlobeNewswire Inc. • 07/18/2025 03:30:23 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/11/2025 10:00:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:26:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:23:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:22:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:21:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:19:20 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 07/01/2025 08:11:31 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 07/01/2025 08:03:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/01/2025 12:38:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/26/2025 08:45:17 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/16/2025 10:16:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/16/2025 10:15:03 AM
- SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN • GlobeNewswire Inc. • 05/23/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 09:13:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 08:17:26 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of SpringWorks Therapeutics, Inc. • PR Newswire (US) • 04/28/2025 09:33:00 PM
